IEFM
JAZZ icon

IQ EQ Fund Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

IQ EQ Fund Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,114
Closed -$2.47M – 295
2023
Q3 		$2.47M Sell
19,114
-6,039
-24% -$805K 0.51% 71
2023
Q2 		$3.12M Hold
25,153
– – 0.59% 69
2023
Q1 		$3.68M Buy
25,153
+1,077
+4% +$159K 0.71% 58
2022
Q4 		$3.84M Buy
24,076
+1,197
+5% +$175K 0.79% 50
2022
Q3 		$3.05M Sell
22,879
-21,079
-48% -$3.21M 0.69% 52
2022
Q2 		$6.86M Buy
43,958
+2,108
+5% +$325K 1.36% 18
2022
Q1 		$6.51M Sell
41,850
-16,812
-29% -$2.44M 1.06% 22
2021
Q4 		$7.47M Buy
58,662
+6,144
+12% +$807K 1.15% 22
2021
Q3 		$6.84M Buy
+52,518
New +$7.93M 1.04% 25

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

IQ EQ Fund Management's JAZZ Position: Q4 2023 in Review

IQ EQ Fund Management sold out of Jazz Pharmaceuticals (JAZZ) in Q4 2023, closing a stake of 19,114 shares — an estimated $2.47M sold.

IQ EQ Fund Management first reported a position in JAZZ in Q3 2021 and held it in 9 quarters. The position peaked at $7.47M in Q4 2021. 500 funds tracked by Wall St. Rank hold JAZZ as of Q4 2023.

  • IQ EQ Fund Management reported no remaining Jazz Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • IQ EQ Fund Management sold 19,114 Jazz Pharmaceuticals shares in Q4 2023, an estimated $2.47M.
  • IQ EQ Fund Management first reported a position in Jazz Pharmaceuticals in Q3 2021 and held it in 9 quarters.
  • IQ EQ Fund Management's Jazz Pharmaceuticals position peaked at $7.47M in Q4 2021.
  • 500 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2023.

Based on IQ EQ Fund Management's 13F filing for Q4 2023, filed 9 Feb 2024.